Order Article Reprints

Edinoff AN, Nix CA, Reed TD, Bozner EM, Alvarez MR, Fuller MC, Anwar F, Cornett EM, Kaye AM, Kaye AD. Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose. Psychiatry International. 2021; 2(4):365-378. https://doi.org/10.3390/psychiatryint2040028

Edinoff, Amber N., Catherine A. Nix, Tanner D. Reed, Elizabeth M. Bozner, Mark R. Alvarez, Mitchell C. Fuller, Fatimah Anwar, Elyse M. Cornett, Adam M. Kaye, and Alan D. Kaye. 2021. "Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose" Psychiatry International 2, no. 4: 365-378. https://doi.org/10.3390/psychiatryint2040028

Edinoff, A. N., Nix, C. A., Reed, T. D., Bozner, E. M., Alvarez, M. R., Fuller, M. C., Anwar, F., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021). Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose. Psychiatry International, 2(4), 365-378. https://doi.org/10.3390/psychiatryint2040028